A systematic review of clinical efficacy and safety of cell-based therapies in Alzheimer's disease.

Hamidreza Feizi Mohammad-Salar Hosseini Sepideh Seyedi-Sahebari Hanie Karimi Reza Mosaddeghi-Heris Saeed Sadigh-Eteghad Fatemeh Sadeghi-Ghyassi Mahnaz Talebi Amirreza Naseri Hanieh Salehi Pourmehr Leila Roshangar

Published in: Dementia & neuropsychologia (2024)

Cell-based therapies are well tolerated by AD patients, which emphasizes the need for further, carefully planned randomized studies to reach evidence-based clinical recommendations in this respect.

Keyphrases

single cell
end stage renal disease
cell therapy
ejection fraction
newly diagnosed
prognostic factors
double blind
peritoneal dialysis
open label
randomized controlled trial
clinical practice
mesenchymal stem cells
study protocol
patient reported
mild cognitive impairment